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Summary  Nocardia  infections  primarily  begin  in  the  lungs  and  spread  hematoge-
nously  to  other  sites  in  the  body.  Thus,  a  Nocardia  brain  abscess  is  not  a completely
uncommon  occurrence.  However,  a  Nocardia  brain  abscess  complicated  by  a  middle
cerebral  artery  and  infectious  intracranial  aneurysm  is  a  very  rare  clinical  entity.
We  present  a  case  of  an  infectious  intracranial  aneurysm  with  an  associated  Nocar-
dia  brain  abscess  that  required  surgical  intervention  and  resection.  The  patient
was  an  immunocompetent  60-year-old  male  who  presented  with  a  chief  complaint
of  headache  and  was  found  to  have  an  infected  intracranial  aneurysm  and  cere-
bral  abscess.  He  underwent  drainage  of  the  abscess  with  subsequent  resection  of
the  infected  aneurysm.  Cultures  from  both  the  blood  vessel  and  brain  tissue  grew
Nocardia  abscessus.  He  was  successfully  treated  with  6  weeks  of  ceftriaxone  and
high-dose  trimethoprim—sulfamethoxazole.  Infectious  intracranial  aneurysms  of  the
brain  caused  by  Nocardia  are  rare  occurrences,  and  only  a  single  previous  case  has
been  described  in  the  literature.  The  outcomes  of  this  condition  can  be  catastrophic
if  it  is  not  treated  with  a  combination  of  surgery  and  intravenous  antibiotics.  The
guidelines  for  the  management  of  this  infection  are  not  well  deﬁned  at  this  time.
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abscess,  but  because  the  patient  was  not  clinically
improving and  still  experiencing  headaches,  fatigue
and memory  loss,  he  underwent  drainage  of  theocardia  abscessus-related  intracranial  aneurysm  
ntroduction
ocardia  is  a  gram-positive,  strictly  aerobic  bacte-
ia and  that  causes  at  least  six  forms  of  disease
n humans  that  include  pulmonary,  systemic,  extra-
ulmonary,  cutaneous,  and  central  nervous  system
CNS) nocardioses  [1]. CNS  nocardiosis  is  usually
econdary  to  lung  or  systemic  nocardiosis,  but  cases
f primary  CNS  infections  have  been  found,  and
rain  abscesses  are  the  characteristic  lesions  of
his type  of  infection  [1,2]. Much  like  CNS  nocar-
iosis, infectious  intracranial  aneurysms  are  rare
nd are  more  closely  associated  with  patients
ho are  immunocompromised  or  have  infective
ndocarditis [3].  Thus,  the  occurrence  of  both
n infectious  intracranial  aneurysm  and  a  brain
bscess  is  very  rare,  and  there  is  only  a  single
ase of  documented  Nocardia-associated  aneurysm
n the  literature  prior  to  this  case  [4].  We  present
 case  of  an  immunocompetent  60-year-old  male
ith an  intracranial  Nocardia  aneurysm  and  associ-
ted Nocardia  brain  abscess  who  required  surgical
ntervention and  resection.
ase report
 60-year-old  male  with  a  benign  past  medical  his-
ory presented  with  headaches,  fatigue,  memory
oss, and  behavioral  abnormalities  for  2—3  weeks
efore  admission.  The  temporal  headaches  were
orsening  signiﬁcantly  with  no  associated  fever  or
hills. The  patient  was  a  relatively  healthy  male
ho lived  at  home  and  did  not  drink,  smoke  or
se drugs.  His  travel  history  was  unremarkable.  In
 recent  physical  performed  by  his  primary  care
hysicians, no  evidence  of  any  obvious  underlying
isease processes,  such  as  cancer,  diabetes  or  HIV,
as found.  A  review  of  systems  was  negative  with
he exception  of  persistent  headaches.  On  physical
xam,  his  vital  signs  were  stable,  his  temperature
as 97.2 ◦F,  blood  pressure  was  130/70,  and  his
ulse  88  beats  per  minute  and  he  had  no  neuro-
ogical deﬁcits.  A  subsequent  CT  scan  revealed  an
bscess  in  the  brain.
MRI  revealed  a  ring-enhancing  lesion  and  a
ossible abscess  next  to  the  aneurysm  (Fig.  1).
T angiogram  revealed  a  clearly  outlined  internal
arotid  aneurysm  (Fig.  2).  His  laboratory  data
ncluded  a  white  blood  cell  count  of  4.0  ×  109
er  liter,  hemoglobin  and  hematocrit  levels  of
4 g/dl  and  44%,  respectively,  and  a  platelet  count
9f 257  ×  10 per  liter.  A  CD4  count  and  IgG  were
ormal, and  blood  cultures  were  negative.  An
chocardiogram  and  chest  X-ray  were  normal.  He
nderwent  a  stereotactic  aspiration  of  the  abscess, Figure  1  MRI  illustrating  a  ring-enhancing  abscess.
hich  grew  Nocardia  abscessus.  The  identiﬁcation
nd conﬁrmation  of  the  pathogen  was  performed
sing the  16s  rRNA  full  sequencing  method.
he pathogen  was  susceptible  to  the  following
ntimicrobial  agents:  cefotaxime,  ceftriaxone,
mipenem, amikacin,  and  sulfonamides.  With  a
iagnosis of  a  primary  CNS  Nocardia  infection,  he
as treated  with  intravenous  injections  of  cef-
riaxone (2  g  IV  every  12  h)  for  a total  period  of  4
eeks but  did  not  improve  and  continued  to  expe-
ience  headaches  without  neurological  deﬁcits.  A
epeated MRI  did  not  reveal  any  worsening  of  theigure  2  CT  angiogram  illustrating  the  aneurysm.
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abscess  with  subsequent  resection  of  the  infected
aneurysm. Cultures  from  both  the  blood  vessel  and
brain tissue  grew  Nocardia  abscessus. He  was  suc-
cessfully  re-treated  with  6 weeks  of  ceftriaxone  and
high-dose  trimethoprim—sulfamethoxazole  (TMP-
SMX) with  success.  Upon  completion  of  treatment,
the patient  reported  that  the  headache  and  fatigue
had resolved.  He  reported  no  memory  loss  or  prob-
lems with  his  vision.  He  has  since  been  followed
up for  approximately  5  months  post-surgery,  and  a
repeat MRI  was  performed  and  revealed  only  resid-
ual surgical  changes  and  no  evidence  of  recurrence.
Discussion
Nocardia  are  ubiquitous,  soil-borne  organisms  that
are most  commonly  introduced  into  the  body  via
the inhalation  of  airborne  conidia  from  the  envi-
ronment.  The  bacteria  can  cause  localized  or
disseminated  infections,  and  the  lungs  are  the  most
common  location  of  primary  infection.  CNS  nocar-
diosis  presents  with  non-speciﬁc  symptoms  and  may
progress rapidly  or  gradually.  Patients  may  present
with signs  of  increased  intracranial  pressure  such
as headache,  nausea,  confusion  and  seizures  [5].
Most frequently,  the  disease  progression  is  grad-
ual, and  neurological  deﬁcits  present  over  a  broad
range  of  time.  CNS  nocardiosis,  unlike  pulmonary
and systemic  infections,  does  not  always  result  in
the clinical  manifestations  of  bacterial  infection
because the  patient  may  not  exhibit  a  fever  or  a
shift in  the  blood  cell  differential  [1].
Nocardia  brain  abscesses  are  very  rare,  they
comprise only  1—2%  of  brain  abscesses,  and  they
have a  high  mortality  rate  [6].  Even  as  sepa-
rate clinical  entities,  Nocardia  brain  abscesses  and
infectious  intracranial  aneurysms  are  rare  and  have
high mortality  rates  [3,7].  Primary  CNS  nocardiosis
without evidence  of  infection  elsewhere  in  the
body represents  8.7%  of  all  Nocardia  infections,  and
of these  CNS  infections,  approximately  40%  occur
in immunocompetent  patients  [1].  In  this  patient,
the infection  appeared  to  be  primary.  There  was
no obvious  occult  site  of  primary  infection,  such  as
in the  lung,  skin,  etc.  We  suspect  that  the  primary
site of  invasion  was  the  endovascular  structure
of the  blood  vessel  with  a  resultant  aneurysm.  A
retrospective  study  of  nocardiosis  cases  in  the  El
Paso area  reported  a  rate  of  58%  in  patients  with
no known  predisposing  factors,  which  may  indicate
that patients  in  this  region  have  an  elevated  risk
of infection  [8]. In  the  previously  mentioned  study,
the incidence  of  primary  nocardia  was  fairly  high,
which may  be  due  to  the  desert  environment  in
which the  patients  lived.  Such  environments  seem
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o  be  conducive  to  the  growth  of  this  pathogen.
here have  been  no  studies  conducted  in  this
egion that  have  addressed  the  Nocardia  infection
isk factors  or  predisposing  factors  since  1999.
erebral nocardiosis  results  in  intra-parenchymal
ncapsulated  abscesses,  which  constitute  only
% of  all  cerebral  abscesses  [9]. The  mortality  of
ocardia  brain  abscesses  is  31%,  which  is  higher
han the  mortality  of  other  brain  abscess-causing
gents [10].  Infectious  intracranial  aneurysms  rep-
esent 0.7—6.5%  of  all  intracranial  aneurysms,  and
he incidence  of  Nocardia-associated  aneurysms
s so  rare  that  only  a  single  case  has  been  doc-
mented in  the  literature  [4].  The  mortality
ates for  infectious  intracranial  aneurysms  are  in
he range  of 80%  following  rupture  and  30%  for
nruptured aneurysms  [7]. The  risk  factors  for
ocardiosis include  underlying  conditions  such  as
ancer, diabetes,  steroid  therapy  and  immune
eﬁciency conditions,  such  as  IgG  deﬁciency.
The identiﬁcation  of  Nocardia  abscessus  is  based
n the  fact  that  this  species  is  a  gram-positive  bacil-
us with  branching  beaded  ﬁlaments  and  is  partially
cid fast.  Species  identiﬁcation  can  be  achieved
sing genus-speciﬁc  16S  rRNA  ampliﬁcation  [11].
The clinical  presentation  of  infectious  intracra-
ial aneurysms  is  similar  to  that  of  other  aneurysms,
ut the  incidence  of  intracerebral  hemorrhage  is
reater [7].
The  main  risk  factor  for  Nocardia  disseminated
nfection is serious  immunosuppression,  such  as
hat observed  in  advanced  HIV  infection,  lym-
horeticular neoplasia,  organ  transplantation,  and
ong-term corticosteroid  use  [12].  Similarly,  the
ajor risk  factors  for  CNS  nocardiosis  and  infec-
ious intracranial  aneurysms  are  immunodeﬁciency
nd infective  endocarditis  [5,7]. In  this  patient,
here was  no  evidence  of  immunodeﬁciency;
owever, primary  nocardiosis  and  actinomycosis  do
ccur in  non-immunocompetent  patients  as  stated
reviously.
The diagnosis  of  a  Nocardia-associated  aneurysm
nd brain  abscess  is  based  on  CT  scans,  MRI  and  MRA
f the  brain  in  addition  to  aspiration  and  culture  of
he abscess.
Ring-enhancing  lesions  on  MRI  are  indicative  of
bscesses  in  the  brain,  and  MR  angiography  can  be
sed to  visualize  the  aneurysm.
Successful  treatment  requires  a  course  of  antibi-
tics with  the  drainage  and  resection  of  the  abscess
nd clipping  of  the  aneurysm  [13].  General  treat-
ent recommendations  for  the  treatment  of  CNS
ocardia  are  limited  by  a  lack  of  prospective  con-
rol trials,  but  drugs  capable  of  penetrating  the
NS, such  as  TMP-SMX  and  ceftriaxone,  have  been
sed in  the  literature  [13]Surgical  intervention  in
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[ocardia  abscessus-related  intracranial  aneurysm  
ombination  with  antimicrobials  may  be  necessary
ue to  the  risk  of  the  failure  of  medical  treatment
lone [3].  Additionally,  patients  with  CNS  nocardio-
is should  receive  antimicrobial  therapy  for  at  least
2 months  with  clinical  monitoring  [14].  Due  to  the
-lactam  susceptibility  pattern  of  N.  abscessus, a
-week treatment  with  ceftriaxone  and  high-dose
MP-SMX proved  to  be  sufﬁcient  for  our  patient.
owever, more  data  are  needed  to  develop  guide-
ines for  the  treatment  of  N.  abscessus-associated
rain abscesses  and  aneurysms.
In conclusion,  primary  brain  abscesses  with
nfectious aneurysms  occur  in  immunocompetent
osts. Clinicians  should  be  aware  of  this  condition
nd treat  it  as  a  life-threatening  condition  with
ggressive  and  rapid  imaging,  neurosurgical  inter-
ention  and  appropriate  antibiotics.  Because  this
ondition  is  so  rare,  deﬁnitive  recommendations
egarding  all  aspects  of  the  condition  cannot  be
ade. If  several  cases  can  be  documented  in  the
iterature,  we  will  be  able  to  make  further  rec-
mmendations that  will  help  clinicians  manage  this
otentially  life-threatening  condition.
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